[SCHEDULE 13D/A] Quipt Home Medical Corp. Amended Major Shareholder Report

Rhea-AI Filing Summary

Quipt Home Medical Corp. has completed its previously announced sale to two buyers, 1567208 B.C. Ltd. and REM Aggregator, LLC. All outstanding common shares were acquired for cash consideration of $3.65 per share, without interest. As a result of this transaction, the reporting investors Forager Fund, L.P., Forager Capital Management, LLC, Edward Kissel, and Robert MacArthur report that they no longer beneficially own any Quipt common shares and now show 0 shares and 0% of the class.

Insights

Event-driven equity analyst

Quipt’s go-private deal closed at $3.65 per share; prior 13D holders exit.

The filing confirms completion of Quipt Home Medical’s sale, with all outstanding common shares acquired for $3.65 per share in cash. This effectively takes the company out of public shareholders’ hands at that price point.

Former significant holders Forager Fund, Forager Capital Management, Edward Kissel, and Robert MacArthur now report 0% beneficial ownership. This signals that the transaction has fully settled from their perspective, with no residual equity stake disclosed in this amendment.

For investors following special situations, this mainly serves as a closing notice on a previously announced Arrangement Agreement. Any future value realization would now depend on the acquiring entities, not on Quipt’s former public listing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 01:46 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 6)

Quipt Home Medical Corp.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

(CUSIP Number)

Robert MacArthur
c/o Forager Fund, L.P.,, 2025 3rd Avenue North, Suite 350
Birmingham, AL, 3520
205-383-4763

Heidi Steele
McDermott Will & Schulte LLP,, 444 West Lake St, Suite 4000
Chicago, IL, 60606
312-984-3624

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

03/16/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP No.

1

Name of reporting person

Forager Fund, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13D

CUSIP No.

1

Name of reporting person

Forager Capital Management, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13D

CUSIP No.

1

Name of reporting person

Kissel Edward Urban

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13D

CUSIP No.

1

Name of reporting person

MacArthur Robert Symmes

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0 %

14

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Shares
(b)	Name of Issuer: Quipt Home Medical Corp.
(c)	Address of Issuer's Principal Executive Offices: 1019 TOWN DRIVE,, WILDER, KENTUCKY , 41076.
Item 1 Comment: This Amendment No. 6 ("Amendment No. 6") amends the statement on Schedule 13D filed with the SEC on December 16, 2025 (as amended from time to time, the "Schedule 13D") with respect to the shares of the Issuer. This Amendment No. 6 to Schedule 13D amends Items 4 and 5 as set forth below. Capitalized terms used herein and not otherwise defined have the meanings set forth in the Schedule 13D/A.
Item 2.	Identity and Background
Item 3.	Source and Amount of Funds or Other Consideration
Item 4.	Purpose of Transaction
	Item 4 is hereby amended and supplemented as follows: On March 16, 2026, pursuant to the Arrangement Agreement and Plan of Arrangement, the previously announced Arrangement among the Issuer, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware company (individually, "REM Aggregator," and collectively with B.C. Purchaser, "Purchaser" or "Purchasers") was completed, upon which all issued and outstanding common shares of the Issuer were acquired by Purchasers for cash consideration of $3.65 per share, without interest.
Item 5.	Interest in Securities of the Issuer
(a)	Item 5(a) is hereby amended and restated in its entirety as follows: As of the close of business on the date hereof, the Reporting Persons no longer may be deemed to beneficially own any common shares.
(b)	Item 5(b) is hereby amended and restated in its entirety as follows: As of the close of business on the date hereof, the Reporting Persons no longer may be deemed to beneficially own any common shares.
(c)	Item 5(c) is hereby amended and restated in its entirety as follows: Except as described herein with respect to the closing of the Arrangement, the Reporting Persons have not effected any transactions in the common shares of the Issuer during the past sixty days.
(e)	Item 5(e) is hereby amended and restated in its entirety as follows: March 16, 2026
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
Item 7.	Material to be Filed as Exhibits.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Forager Fund, L.P.

Signature:	/s/ Robert MacArthur
Name/Title:	Robert MacArthur, Managing Partner
Date:	03/16/2026

Forager Capital Management, LLC

Signature:	/s/ Robert MacArthur
Name/Title:	Robert MacArthur, Managing Partner
Date:	03/16/2026

Kissel Edward Urban

Signature:	/s/ Edward Kissel
Name/Title:	Edward Kissel
Date:	03/16/2026

MacArthur Robert Symmes

Signature:	/s/ Robert MacArthur
Name/Title:	Robert MacArthur
Date:	03/16/2026